Researchers added paricalcitol to chemotherapy and assessed outcomes in metastatic pancreatic cancer. The treatment remodeled ...
A small clinical trial led by Dana-Farber Cancer Institute researchers has put a Salk Institute idea to the test in patients: ...
CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of ...
Renewed pharma interest in GPCR biology and radioligand therapies is drawing attention to functional peptide screening ...
GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking ...
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors ...
Preclinical studies at the Salk Institute laid the foundation for a question now being tested in patients: Can a vitamin ...
Despite impressive innovations in medicine, most advanced-stage cancers still carry a grim prognosis. Developing more ...
A small clinical trial led by Dana-Farber Cancer Institute researchers put a Salk Institute idea to the test in patients: ...
Announced selection of rinzimetostat RP3D in combination with darolutamide for Himalayas-1 Phase 3 global registrational trial in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results